|
|
|
| Oral Ca as appropriate for screening: |
||
| Has a pre-clinical detectable period? |
||
|
|
|
|
|
|
| n | Often preceded by
potentially malignant |
||||
| lesions/
conditions such as leukoplakia, |
|||||
| erythroplakia,
and submucous fibrosis |
|||||
| n | Major sites of
occurrence readily accessible |
||||
| to examination |
|||||
| ohcd4_03 |
| 19 |